183 (15%) EBITDA 27 33 22% 86 90 5% Net Profit(Loss) for the Company (3) (7) (133%) 10 4 (60%) Gross Profit Margin (%) 54.9% 56.2% 1.3% 59.5% 57.7% (1.8%) EBITDA Margin1 (%) 18.6% 23.9% 5.3% 23.6% 28.2

67.37 (17.72) (20.83%) Income tax expenses 52.64 59.19 6.55 12.44% Net profit 187.67 227.68 40.01 21.32% Net profit ratio (ROS) 16.24% 16.00% Earnings per share (Baht) 0.45 0.42 (0.03) (6.67%) 1. Overview

decreasing in total revenue from sales. The consolidated gross profit margin contributed of 14.30% in 2Q2020, slightly increased from 13.87% in 2Q2019. The participating profit from associates was THB 84.96

, increased by 33.1 Million Baht or 8.9% compared to the previous year, which contributes 35% of total revenue as the Company has improved customer portfolio by focus more on high margin SKUs which results in

beverages of Baht 1,194 million decreased from 2018 by Baht 1,240 million or by 51%. This was due to closure of all six DEAN & DELUCA stores in the United States and two stores in Thailand. Other income

of electricity 117.28 114.56 2.72 2.37 5 Other income 1.44 11.77 (10.33) (87.77) Unit : Million Baht For the three-months ended 30 June Items Increased (Decreased) 2019 2018 Amount Percentage 6 Total

with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000

54% Related technology business 362 19% 283 22% 79 28% Retail business 812 42% 537 41% 275 51% Total revenues from main business 1,858 97% 1,269 97% 589 46% Other income 51 3% 38 3% 13 34% Total

project management 195.2 4.7 280.0 8.4 84.8 43.4 Dividend income - - 0.3 - 0.3 100.0 Gain from transfer of right for land purchase and sale agreement 312.0 7.5 - - (312.0) (100.0) Gain on disposals of

last year. Profit & Loss Analysis (Unit : Million Baht unless otherwise stated) Quarter 3 Change 2018 2017 Amount % Change Total Revenues 4,416 4,284 132 +3.1% Sales and service income 4,179 4,052 127